Contents
On this page
- The ingredient list and the findings of the expert rating exercise
- Functions of each ingredient
- Ingredients most often underdeveloped
- Non-scientific ingredients
- Distinction between the proposal and the protocol
- Allocation of the ingredients within page limits
- Reviewer weighting of the ingredients
- Recommended order of assembly
- Elements omitted from standard ingredient lists
- Key points
- Application to your study
- Frequently asked questions
Academy · Research Writing · medical proposal ingredients
The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria
Ten key ingredients of a health research proposal have been identified and rated for importance by nine experts, six of whom were journal editorial board members. Identifying these components is comparatively straightforward. The greater difficulty is that three of them — a theoretical framework, sufficient preliminary data and adequate statistical consideration — are among the weaknesses most frequently recorded by peer reviewers, which indicates that many proposals contain all ten ingredients but develop three of them inadequately.
A proposal with a missing section is uncommon. A proposal with a section present in name but absent in substance is typical, and it is this that reviewers record when they list 19 recurring weaknesses, including no theoretical framework, insufficient preliminary data and inadequate statistical consideration. This article examines each ingredient in terms of the function it must serve for a reader rather than its title, and it also addresses the non-scientific ingredients, because missed deadlines, format breaches and unrealistic budgets are among the 15 standard reasons for which proposals are rejected.
Learning objectives
- The function that each component of a medical research proposal must serve for a reader
- The three ingredients most often present in name but underdeveloped in substance
- The non-scientific ingredients that cause rejection before review — deadlines, format and budget realism
- The distinction between a proposal and a protocol, and which of the 34 SPIRIT 2025 protocol items the proposal must still contain
- Accommodating the full ingredient list within a 15-page technical volume
- The weighting of the ingredients by reviewers across nine criterion domains
Common misconceptions
- “If every section is present, the proposal is complete.” Reviewers record 19 recurring weaknesses, several of which describe sections that are present but serve no function — no theoretical framework, insufficient preliminary data and inadequate statistical consideration. The presence of a section is not evidence of its substance.
- “Proposals are rejected on science.” The 15 recurring reasons for rejection include missed deadlines, format breaches and unrealistic budgets. These are avoidable at no cost, yet they halt applications before the science is assessed.
- “The ingredients are equally weighted.” Reviewers apply nine criterion domains, and originality ranked first for 12 of 34 reviewers compared with methodology for 10. No single ingredient dominates, but the ingredients are not interchangeable.
- “The proposal is a short protocol.” Protocol reporting standards specify a minimum set of items (34 in SPIRIT 2025), and a page-limited proposal cannot contain all of them. It must contain those that determine cost, feasibility and interpretation, and reference the remainder.
- “Statistical consideration means stating the sample size.” A number unsupported by stated assumptions is the version that reviewers record as inadequate. The ingredient is the reasoning: the comparison, the effect size and its source, and the consequences if the assumptions prove incorrect.
The ingredient list and the findings of the expert rating exercise
Ten key ingredients have been identified as required in a health research proposal, and rated for importance by a panel of nine experts, six of whom were journal editorial board members 34. Two features of that exercise merit attention before the list itself.
First, the ingredients were rated, which means they are not equivalent. A proposal that devotes equal effort to each misallocates that effort, and the allocation question — which section merits the next page — is a substantive decision rather than a formatting one. Second, the panel was weighted toward journal editors rather than funders, which is relevant: editors and reviewers of the eventual publication value some elements more than a funding panel does, and others less. The overlap is large but not complete.
The components below are the standard content of a health research proposal as the funding and reporting literature describes them, grouped by the function each serves 6,34. They are presented by function rather than as a numbered list because function can be checked: a section can be named correctly and still fail to serve its purpose, which is precisely what the catalogues of reviewer weaknesses record. Our page on grant proposal writing for medical research covers the submission cycle around these ingredients, and proposal development support is where we work on them.
The ingredient set was rated rather than merely listed, which means the components are not equivalent and the allocation of effort between them is a substantive decision. The panel composition should be noted: it was weighted toward journal editors rather than funding reviewers.
Functions of each ingredient
The title. Names the population, the intervention or exposure, and the outcome. A title that names only a topic and a method omits the information a reader most requires.
The abstract or summary. The only part that some assessors read in full, and the part that determines whether the application passes triage 21. It should state the question, the design, the population, the primary outcome and the deliverable — in that order, without ornamental content.
The background and rationale. Establishes what is known, what is not, and why the gap matters. This is where an underdeveloped scientific foundation is identified, and the assessment depends on whether the section argues or merely summarises. See our page on writing the rationale.
The theoretical or conceptual framework. States the mechanism or model believed to be operating, with sufficient specificity to predict an observation. Its absence is one of the recorded weaknesses, and it is the ingredient most often omitted in laboratory and clinical proposals on the assumption that it belongs to social science 29.
The objectives. One primary objective, a bounded set of secondaries, each with a measurable endpoint 23. The whole proposal is sized and judged against this ingredient.
The design and methods. The population, the comparator, the allocation if any, the measurement and the procedures. The criterion is reproducibility: whether a competent reader could carry out the study as described.
The statistical consideration. Not a sample size alone but the reasoning that produces one, together with the analysis plan for each objective and the handling of missing data. It is recorded as inadequate more often than almost any other ingredient.
Preliminary data. Evidence that the applicants can do what they propose — produce the material, measure the endpoint, recruit the population. Insufficient preliminary data is a named weakness, and in practice it usually reflects capability asserted rather than demonstrated.
Feasibility, team and environment. Who does which part, with what access, under what arrangement 13. A named person with an unspecified contribution weakens the application more than the absence of a name.
Ethics and governance. Consent, approval route, data protection, and the handling of vulnerable groups 4. See regulatory measures for research involving human participants.
Timeline and milestones. The work divided into units with dates and deliverables, consistent with the budget.
Budget and justification. Costed by task rather than by role, with the lines that are commonly under-costed — data management, monitoring, statistical input, governance — included rather than assumed 5.
Dissemination and output. What will be published, when, and to whom else the results will be communicated.
The ingredients of a medical research proposal, by the function each serves
| Ingredient | What it must accomplish | How it usually fails |
|---|---|---|
| Title | Name the population, the intervention or exposure, and the outcome | Names a topic and a technique, omitting the most useful information |
| Abstract or summary | State the question, design, population, primary outcome and deliverable — this is what passes triage | Written first, so it states intent rather than content |
| Background and rationale | Make the objectives unavoidable | Summarises a field instead of arguing a gap |
| Theoretical or conceptual framework | Commit to a mechanism specific enough to predict an observation | Named and never used again — a recorded reviewer weakness |
| Objectives | One primary, a bounded set of secondaries, each with a measurable endpoint | Several co-primary objectives, so nothing is prioritised |
| Design and methods | Be reproducible by a competent reader | Describes intent rather than procedure |
| Statistical consideration | Show the reasoning that produces the sample size, plus the analysis plan and missing-data handling | A number with no assumptions — a recorded reviewer weakness |
| Preliminary data | Evidence that the applicants can do what they propose | Capability asserted rather than shown — a recorded reviewer weakness |
| Feasibility, team and environment | State who does which part, with what access and under what arrangement | Named people with unspecified contributions |
| Ethics and governance | Consent, approval route, data protection, vulnerable groups | Treated as a form rather than as content |
| Timeline and milestones | Divide the work into dated units with deliverables | A Gantt chart that does not reconcile with the budget |
| Budget and justification | Cost by task, including data management, monitoring and statistical input | Costed by role, with less visible budget lines omitted |
| Dissemination and output | State what is published, when, and who else receives the results | A sentence about conferences with no deliverable attached |
Component set as described in the health research proposal literature, in which ten key ingredients were identified and rated for importance by nine experts, six of them journal editorial board members. The failure column draws on the 19 weaknesses peer reviewers commonly record and the 15 recurring reasons for rejection.
Ingredients most often underdeveloped
Nineteen distinct weaknesses are commonly recorded by peer reviewers, and three of them name ingredients that proposals almost always contain: no theoretical framework, insufficient preliminary data, inadequate statistical consideration 29. The pattern is informative. These are not sections that writers forget; they are sections that writers complete without supplying substantive content.
The theoretical framework fails when it is named rather than used. The diagnostic test is deletion: if, after every sentence mentioning the framework is removed, the objectives, the measurements and the analysis are unchanged, the framework served no analytical function. The remedy is a paragraph that commits to a mechanism and generates a prediction, after which the objectives follow from it rather than standing alongside it.
Preliminary data fail when capability is asserted. “We have established this assay”, “we have access to this cohort”, “our group routinely performs this procedure” — each is a claim with no evidence attached. The remedy is to convert each assertion into an evidenced claim with a figure, a reproducibility statistic, an accrual record or a named arrangement, and to state clearly where no data exist, together with the mitigation.
Statistical consideration fails when a number appears without its assumptions. A sample size is the output of a calculation whose inputs are the comparison, the expected effect, the variability, the acceptable error rates and the anticipated attrition. Reviewers record inadequacy when the inputs are absent, because without them the number cannot be evaluated and the study cannot be judged capable of answering its own question. The before-and-after example below illustrates this remedy.
Our pages on background and framework writing and biostatistics support cover the first and third of these in depth.
The statistical consideration section
A number with no assumptions behind it
Sample size: Based on a power calculation, a total of [n] participants will be recruited. This sample size will provide adequate power to detect a clinically significant difference between groups. Data will be analysed using appropriate statistical tests, and a p value of less than 0.05 will be considered statistically significant. Missing data will be handled appropriately.
“Based on a power calculation” names no inputs. Without the comparison, the effect size, the variability, the error rates and the attrition assumption, the number cannot be evaluated — which is precisely what reviewers record as inadequate statistical consideration.
“Clinically significant difference” is never specified. The target difference is a judgement that must be stated and sourced, because the whole calculation depends on it.
“Appropriate statistical tests” defers the analysis plan indefinitely. A reviewer cannot determine whether the analysis matches the design, and the author has reserved the right to decide after seeing the data.
A p value threshold is quoted in place of an analysis. It states what will be called significant, not what will be estimated or compared.
“Missing data will be handled appropriately” is a placeholder. In most clinical and questionnaire studies missingness is the normal condition, not an exceptional case, and a rule chosen after the fact is not credible.
No statistician is named. A section not written by a statistician is usually recognisable as such, and the absence of a named statistician with allocated effort confirms it.
A calculation a reviewer can evaluate
The primary comparison is the between-arm difference in [outcome] at [time point], analysed as [specified model] with [covariates] adjusted for, as pre-specified in the statistical analysis plan. The target difference is [effect], which we take as the minimum clinically important difference on the grounds that [source — a published anchor-based estimate, a guideline threshold, or a stakeholder consensus, cited]; we note that this is a judgement and report in the limitations what the study would and would not detect if the true difference were half of it. Variability is taken from [source], which gives a standard deviation of [value] in a population comparable to ours in [respects]. At two-sided alpha of [value] and power of [value] this requires [n] participants per arm. We inflate to [n] per arm for anticipated attrition of [rate], which is the rate observed in [source] rather than an assumption. Randomisation is [ratio]; the [design feature, e.g. cluster] structure is accounted for with an intracluster correlation of [value] from [source], giving a design effect of [value] and a final target of [n]. Secondary objectives are analysed as set out in the analysis plan and are not powered individually; we report them as estimates with intervals and make no inferential claim, which is stated in the objectives section as well as here. Missing primary-outcome data will be handled by [named approach] under a [stated] assumption, with a sensitivity analysis under [alternative assumption]; the rule for when a participant is treated as having missing primary outcome data is fixed in the protocol before recruitment opens. A named statistician, [name], is a co-investigator at [effort] and wrote this section.
Every input to the calculation is stated with its source, so a reviewer can reproduce the number or disagree with a specific assumption rather than with the whole section.
The target difference is identified as a judgement and sourced, and the consequence of being wrong about it is reported in the limitations.
The analysis is named with the comparison it tests, so the design and the analysis can be checked against each other.
Attrition and, where relevant, clustering are handled with figures taken from sources rather than assumed, which is where sample sizes most often go wrong.
Secondary objectives are explicitly not powered and are reported as estimates, which anticipates the multiplicity objection rather than inviting it.
The missing-data approach, its assumption and a sensitivity analysis are pre-specified, and the definition of missing is fixed before recruitment.
A statistician is named with allocated effort, which answers the credibility question the section otherwise raises.
Inadequate statistical consideration is one of the weaknesses that peer reviewers record most often, and it is almost always identified from a sample size presented without its inputs. The second version is one paragraph longer and converts an unverifiable claim into a set of verifiable ones.
Non-scientific ingredients
Fifteen recurring reasons account for most rejections, and they range from missed deadlines and format breaches to unrealistic budgets 37. These merit separation from the scientific weaknesses because they are entirely avoidable and because they operate earlier — an application that breaches a format rule or arrives late may never reach the scientific assessment at all.
The administrative ingredients are therefore genuine ingredients. Compliance with the call: page limits, font and margin rules, section order, word counts, whether references count against the limit. Eligibility: career stage, host institution, concurrent-application rules, resubmission restrictions. Completeness of the attachment set: every letter, CV, biosketch, facilities statement and data-management plan the call lists. The deadline and the institutional cut-off, which are two different dates. And budget realism, which appears scientific but is not: a budget that is implausibly low suggests a plan that is not understood, and one that is implausibly high suggests a plan that has not been costed.
The most valuable hour in any application is that spent reading the call document completely and recording every limit, rule, date and required attachment it contains. It is also the hour most often omitted, because it produces no prose. Our page on why manuscripts are rejected covers the analogous list on the publication side, where format and scope breaches behave the same way.
The non-scientific ingredients, and when they take effect
| Ingredient | What to check | When it stops the application |
|---|---|---|
| Deadline compliance | Sponsor deadline and institutional cut-off are two different dates | Before any assessment |
| Format compliance | Page limits, font, margins, section order, whether references count | Before any assessment — among the standard rejection reasons |
| Eligibility | Career stage, host institution, concurrent and resubmission rules | Before any assessment |
| Attachment completeness | Every letter, CV, biosketch, facilities statement and plan the call lists | Before or at administrative screening |
| Budget realism | Too low suggests a plan not understood; too high, a plan not costed | During assessment, as a feasibility judgement |
Drawn from the 15 recurring reasons for which proposals are rejected, which range from missed deadlines and format breaches to unrealistic budgets.
Distinction between the proposal and the protocol
The minimum protocol content for a trial is 34 specified items in SPIRIT 2025, and a page-limited proposal cannot carry them all 31. The two documents serve different purposes: the proposal argues that the study should be funded, whereas the protocol specifies how it will be conducted. The separation is not absolute, however, because several protocol items are what make the proposal’s argument credible.
The items the proposal must contain are those that determine cost, feasibility or interpretation: the primary outcome and how it is measured, because it determines the sample size and the budget; the eligibility criteria, because they determine the recruitment rate; the analysis plan, at least in outline, because without it the sizing cannot be assessed; the monitoring and data-management arrangements, because they are a cost that reviewers check; and the governance route with its lead time, because an approval that cannot be obtained within the award period is a feasibility problem rather than an administrative one.
Everything else — the full schedule of assessments, the detailed procedures, the data-collection instruments, the committee structures — belongs in the protocol, which the proposal references 25. The proposal should state explicitly that the protocol exists or when it will exist, and name the standard it follows. A proposal that mentions no protocol invites the reasonable inference that the study has not yet been designed in that degree of detail. The SPIRIT checklist lists the items; protocol development and our page on writing an article from a protocol cover the later life of the document.
Allocation of the ingredients within page limits
A typical structural budget for a proposal is no more than 15 pages of technical content with a one-page introduction, a research plan built as two to three thrusts, and a term of three to five years 22,37. Fitting thirteen ingredients into fifteen pages makes allocation the central drafting decision, and it must be made before writing rather than discovered during it.
Space should be allocated according to what a reader needs rather than what the applicant wishes to say. The introduction is conventionally limited to one page and should remain so. Objectives are concise by nature. Design and methods take the largest share, because that is where feasibility and rigour are demonstrated and where doubts about execution are addressed. Statistical consideration merits more space than it usually receives — a well-argued half page is of greater value than three pages of methods detail. Preliminary data should occupy whatever space is needed to resolve the central feasibility doubt and no more. Background and rationale should be shorter than most applicants write: the section exists to make the objectives compelling, and once that is achieved it has served its purpose.
Two practical rules apply. The allocation should be written down and kept visible, so that an overrunning section must be traded against another rather than silently absorbing the space. When the total will not fit, scope rather than detail should be reduced — a two-thrust plan described adequately is preferable to a three-thrust plan described superficially, because a superficial description is precisely what reviewers record as an inexecutable plan. Our page on proposal structure works through the allocation arithmetic.
Reviewer weighting of the ingredients
Reviewers apply nine criterion domains, and among 34 reviewers, originality ranked first for 12 and methodology for 10 32. Two conclusions follow, and they point in usefully different directions.
The first is that originality and methodology together account for the stated top priority of the majority of reviewers, which supports concentrating the strongest writing on the novelty claim and the methods. The second is that neither constitutes a majority on its own: roughly two in three reviewers lead with something other than originality, and roughly seven in ten with something other than methodology. No single ingredient can safely be relied upon.
The practical consequence is a strategy of defensibility rather than of distinction. The weakest ingredient should be raised to an adequate standard before the strongest is raised from good to excellent, because the weak ingredient determines the outcome whenever a reviewer who prioritises that dimension leads the discussion. This recommendation follows from the distribution of reviewer priorities.
The same distribution informs the briefing of a pre-submission reader, who should be asked to identify the weakest ingredient rather than to comment on the whole. Our page on using scientific experts before submission covers how to commission that read, and why agreement between panel reviewers is low enough to make it worth doing.
Recommended order of assembly
The ingredients are not written in the order in which they appear. The sequence that avoids rework is as follows: objectives first, because everything is sized and judged against them; then the design and methods that can address them; then the statistical consideration, which depends on both; then the cost-driving protocol decisions; then the budget and timeline, which depend on all of the above; then preliminary data and feasibility, assembled to resolve the specific doubts the plan has created; then background and rationale, written to make the objectives compelling; then the framework, which is in effect an earlier commitment made explicit; then the abstract; and the title last 20,33.
Writing the title and abstract last is not a stylistic preference. Both are summaries, and a summary written before the document it summarises is a statement of intent that then constrains the document. Writing the background after the methods is similarly deliberate: the premises a reader needs cannot be known until the proposal itself is defined.
One cross-check at the end, done as a separate pass: the objectives, the methods, the statistical consideration, the timeline and the budget should all describe the same study, with the same labels and the same numbers. Drift between them is common, it is what reviewers find when they reconcile documents, and it is invisible to an author reading sequentially.
Elements omitted from standard ingredient lists
Ingredient lists are useful but incomplete, and their omissions merit explicit statement.
They do not capture internal consistency, which is not a section and is checked more reliably than any individual section. A proposal can have thirteen strong ingredients that describe four slightly different studies.
They do not capture the declared risk. No standard list has an item for “the things that could go wrong, named by the applicant, with mitigations”, and yet a plan with named risks reads as competence while a plan whose risks the reviewer discovers reads as ignorance or concealment.
They do not capture the negative result. A proposal that is of interest only if the hypothesis is confirmed is weaker than one in which both outcomes are informative, and no ingredient list requires this to be checked.
And they do not capture legibility to a non-specialist. Panels are mixed, triage is often conducted quickly, and the application will be summarised to the panel by one person. Whether a competent non-specialist can follow the mechanism is not a listed ingredient, yet it influences outcomes.
These four elements should be added as a final review. They require little additional time and distinguish a complete proposal from a convincing one. For writing support with that review, see medical writing and grant writing services.
Key points
Key points
Ten key ingredients of a health research proposal have been identified and rated for importance by nine experts, six of whom were journal editorial board members; the components are therefore not equivalent, and the allocation of effort between them is a substantive decision. Almost every proposal contains every ingredient; the 19 recurring weaknesses recorded by reviewers describe ingredients present in name but underdeveloped in substance, principally a theoretical framework that is named rather than applied, preliminary data that assert capability rather than evidence it, and a sample size reported without the assumptions from which it was derived. The non-scientific ingredients also require attention: missed deadlines, format breaches and unrealistic budgets are among the 15 standard reasons for rejection and operate before any scientific assessment. The ingredients should be fitted to the page budget deliberately — no more than 15 pages of technical content, with a one-page introduction and a plan of two to three thrusts — and, because reviewer priorities are distributed across nine criterion domains, with originality leading for 12 of 34 reviewers and methodology for 10, the weakest ingredient should be raised to an adequate standard before the strongest is further improved.
Application to your study
Application to your study
- The proposal should be audited by function rather than by heading. For each ingredient, the function it must serve should be recorded and the sentence in the draft that serves it identified. A heading without such a sentence indicates a gap.
- The framework deletion test should be applied. Every mention of the theoretical framework is removed; if the objectives, measurements and analysis are unchanged, the framework served no analytical function.
- Every assertion of capability should be converted into an evidenced claim. Each statement of the form “we have established” requires a figure, a reproducibility statistic, an accrual record or a named arrangement in support.
- The statistical consideration should be reconstructed from its inputs. These comprise the comparison, the target difference and its source, the variability and its source, error rates, attrition and its source, the analysis plan and the missing-data rule, together with a named statistician with allocated effort.
- The call document should be reviewed in detail. Every page limit, format rule, eligibility condition, required attachment and both deadlines should be recorded. This is the least costly cause of rejection to avoid.
- The page budget should be allocated before drafting begins. The introduction should be limited to one page, the methods given the largest share, and scope rather than detail reduced when the total exceeds the limit.
- The weakest ingredient should be identified and addressed first. Because reviewer priorities are distributed across nine domains, a weak section may determine the outcome whenever the lead reviewer prioritises it.
- Four elements absent from standard ingredient lists should be added. These are internal consistency across documents, risks identified by the applicants themselves, a design in which a negative result remains informative, and legibility to a competent non-specialist.
Frequently asked questions
Ten key ingredients have been identified as required in a health research proposal and rated for importance by nine experts, six of them journal editorial board members. In practice the components to be included are: a title naming population, intervention and outcome; an abstract that passes triage; background and rationale that make the objectives compelling; a theoretical or conceptual framework; one primary and a bounded set of secondary objectives; design and methods that a competent reader could reproduce; statistical consideration; preliminary data; feasibility, team and environment; ethics and governance; a timeline with milestones; a budget costed by task; and a dissemination plan. The relevant question is not whether each is present — in most proposals they all are — but whether each serves its function.
Nineteen distinct weaknesses are commonly recorded by peer reviewers, and three of them name sections that proposals almost always contain: no theoretical framework, insufficient preliminary data and inadequate statistical consideration. The pattern is significant: these are not forgotten sections but completed sections without substantive content. The framework fails when it is named and never used again; preliminary data fail when capability is asserted rather than evidenced; statistical consideration fails when a sample size appears without the comparison, effect size, variability, error rates and attrition assumption that produced it. Separately, the 15 recurring reasons for rejection include missed deadlines, format breaches and unrealistic budgets, which operate before the science is assessed at all.
Yes, although not in the form the phrase suggests. A missing theoretical framework is one of the weaknesses that reviewers commonly record, across biomedical and health research rather than only in social science. What is required is a statement of the mechanism or model believed to be operating, specific enough to predict an observation: what should be observed if the hypothesis is correct, and what if it is not. It need not be a named model. The test is mechanical — if, after every sentence mentioning the framework is deleted, the objectives, measurements and analysis plan are unchanged, the framework served no analytical function. It should either be made load-bearing, so that the objectives follow from it, or the work should be declared descriptive and that choice justified.
The reasoning rather than the number. The primary comparison and the analysis that tests it should be named. The target difference and its origin should be stated, with acknowledgement that it is a judgement and a report of what the study would fail to detect if the true difference were smaller. The variability should be stated with its source and the population from which it derives, and the error rates should be specified. Attrition should be accounted for using an observed rate rather than an assumption, and clustering should be accounted for if the design involves it. The proposal should state that secondary objectives are not individually powered and will be reported as estimates. The missing-data approach, its assumption, a sensitivity analysis and the rule for when an outcome counts as missing should be pre-specified. Finally, a statistician with allocated effort should be named.
Sufficient to resolve the specific feasibility doubts the plan creates, and no more — preliminary data compete for the same pages as the methods. Insufficient preliminary data is a named reviewer weakness, and in practice it is identified not from an absence of data but from assertions in their place: we have established this assay, we have access to this cohort, our group routinely performs this procedure. Each of those requires supporting evidence: a figure, a reproducibility statistic, an accrual record, a named arrangement with a letter. Where no data exist for a step, this should be stated together with the mitigation. A declared gap with a plan is acceptable; a gap that the reviewer identifies by inference is not.
They serve different purposes. The proposal argues that the study should be funded; the protocol specifies how it will be conducted, and protocol reporting standards set a minimum of 34 items in SPIRIT 2025. A page-limited proposal cannot contain all 34 and should not attempt to. It must contain the items that determine cost, feasibility or interpretation: the primary outcome and its measurement, because it determines the sample size and the budget; the eligibility criteria, because they determine the recruitment rate; the analysis plan at least in outline; the monitoring and data-management arrangements, because reviewers check that they are costed; and the governance route with its lead time. The remainder belongs in the protocol, which the proposal should reference, stating whether it exists or when it will be completed.
Before drafting, in writing, and on the basis of what a reader needs. A typical structural budget is no more than 15 pages of technical content with a one-page introduction and a plan of two to three thrusts over a three to five year term. The introduction should be limited to one page. Design and methods should receive the largest share, since that is where rigour is demonstrated and doubts about execution are addressed. Statistical consideration should receive more space than it usually does, because a well-argued half page is of greater value than additional methods detail. The background should be shorter than applicants tend to make it — it exists to make the objectives compelling and has served its purpose once that is achieved. When the total will not fit, scope rather than detail should be reduced: a two-thrust plan described adequately is preferable to a three-thrust plan described superficially.
Not in the order in which they appear. Objectives first, since everything is sized and judged against them; then design and methods; then statistical consideration, which depends on both; then the cost-driving protocol decisions; then budget and timeline; then preliminary data and feasibility, assembled to resolve the specific doubts the plan has created; then background and rationale, written to make the objectives compelling; then the framework made explicit; then the abstract; and the title last. The title and abstract are summaries, and a summary written first becomes a statement of intent that constrains the document. A separate reconciliation pass should conclude the process: objectives, methods, statistics, timeline and budget must describe the same study with the same labels and numbers.
References
- Muhlenberg M, Wassmer T. Writing Research and Grant Proposals. Field Ecology (Springer, Cham). 2025:515-517. doi:10.1007/978-3-031-87547-2_16 read 9 October 2026. doi.org/10.1007/978-3-031-87547-2_16
- Willis LD. Formulating the Research Question and Framing the Hypothesis. Respiratory Care. 2024;69(4). doi:10.4187/respcare.10975 read 9 October 2026. doi.org/10.4187/respcare.10975
- Munch LN, Schuttler KF, Ackermann J, et al. Writing a research funding proposal. Arthroskopie. 2024;37(4):250-253. doi:10.1007/s00142-024-00690-x read 9 October 2026. doi.org/10.1007/s00142-024-00690-x
- Agreement and MOU: Ethical and Legal Aspects of Funding for Healthcare Research. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:103-116. doi:10.1007/978-981-19-7018-4_9 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_9
- Patil SG. Budgeting the Project: Detailing the Required Funding and Expenditure. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:77-91. doi:10.1007/978-981-19-7018-4_7 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_7
- Rajappa M. Checklist for Grant Proposal: Mandatory Elements. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:161-165. doi:10.1007/978-981-19-7018-4_14 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_14
- Joshi M, Joshi P, Smith JA. Dealing with the Rejected Grant Proposal: Learning from the Mistakes. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:179-187. doi:10.1007/978-981-19-7018-4_16 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_16
- Rahi M, Sharma S, Yadav B. Funders' Perspective: What the Funding Body Expects from Researchers? Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:21-31. doi:10.1007/978-981-19-7018-4_3 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_3
- Dubashi B, Ramadass B. Funding Organizations for Science and Health Care. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:33-52. doi:10.1007/978-981-19-7018-4_4 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_4
- Parija SC, Kate V (eds). Grant writing for medical and healthcare professionals. Springer, Singapore. 2023. doi:10.1007/978-981-19-7018-4 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4
- Weidmann AE, Cadogan CA, Fialova D, et al. How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy. 2023;45(3):781-786. doi:10.1007/s11096-023-01543-7 read 9 October 2026. doi.org/10.1007/s11096-023-01543-7
- Obtaining Letters of Support. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:53-59. doi:10.1007/978-981-19-7018-4_5 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_5
- Singaravelu SLD. Proving the Competency of the Researcher and the Adequacy of the Infrastructure to Carry Out the Research. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:93-101. doi:10.1007/978-981-19-7018-4_8 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_8
- Subramanian K, Muthuramalingam A, Chandrasekaran V. Sources of Funding and Acknowledgement: Good Clinical Practice Guidelines. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:145-152. doi:10.1007/978-981-19-7018-4_12 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_12
- Surveillance Plan and Site Visit: Roles and Rights of the Researcher and the Funding Agency. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:133-144. doi:10.1007/978-981-19-7018-4_11 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_11
- Nachiappa Ganesh R. Tips for Improvising the Chance of Getting the Grant. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:167-177. doi:10.1007/978-981-19-7018-4_15 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_15
- Parija SC, Shrivastava SR. What Is Your Aim (Ambition-Interest-Mission), and What You Want to Do? Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:3-12. doi:10.1007/978-981-19-7018-4_1 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_1
- What Is a Grant? How to Prepare a Grant Proposal Application. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:13-20. doi:10.1007/978-981-19-7018-4_2 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_2
- Barreto SG. Writing a Grant Proposal for a Collaborative Study. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:153-159. doi:10.1007/978-981-19-7018-4_13 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_13
- Kate V, Gupta D, Balakrishnan G. Writing a Grant Proposal for a Single Centre Study: Step-by-Step Approach. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:63-76. doi:10.1007/978-981-19-7018-4_6 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_6
- Ganguly NK, Saha GK. Writing an Impressive Cover Page (Covering Letter) and Abstract for Grant Proposal Application. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:117-131. doi:10.1007/978-981-19-7018-4_10 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_10
- Monavarian M. Basics of scientific and technical writing: Grant proposals. MRS Bulletin. 2021;46(5):455-457. doi:10.1557/s43577-021-00105-4 read 9 October 2026. doi.org/10.1557/s43577-021-00105-4
- Dhir SK, Gupta P. Formulation of Research Question and Composing Study Outcomes and Objectives. Indian Pediatrics. 2021;58:584-588. read 9 October 2026. indianpediatrics.net
- Kan P, Mokin M, Mack WJ, et al. Strategies for writing a successful National Institutes of Health grant proposal for the early-career neurointerventionalist. Journal of NeuroInterventional Surgery. 2020. doi:10.1136/neurintsurg-2020-016964 read 9 October 2026. doi.org/10.1136/neurintsurg-2020-016964
- Taylor RB. How to Write a Research Protocol. Medical Writing (Springer, Cham). 2018:239-260. doi:10.1007/978-3-319-70126-4_9 read 9 October 2026. doi.org/10.1007/978-3-319-70126-4_9
- Shepherd J, Frampton GK, Pickett K, et al. Peer review of health research funding proposals: A systematic map and systematic review of innovations for effectiveness and efficiency. PLoS ONE. 2018;13(5):e0196914. doi:10.1371/journal.pone.0196914 read 9 October 2026. doi.org/10.1371/journal.pone.0196914
- Boyack KW, Smith C, Klavans R. Toward predicting research proposal success. Scientometrics. 2018;114(2):449-461. doi:10.1007/s11192-017-2609-2 read 9 October 2026. doi.org/10.1007/s11192-017-2609-2
- Barnett AG, Herbert DL, Campbell M, et al. Streamlined research funding using short proposals and accelerated peer review: an observational study. BMC Health Services Research. 2015;15(1):55. doi:10.1186/s12913-015-0721-7 read 9 October 2026. doi.org/10.1186/s12913-015-0721-7
- Agency for Healthcare Research and Quality. Common Problems Identified During Peer Review. Agency for Healthcare Research and Quality (AHRQ). 2014. read 9 October 2026. ahrq.gov
- Herbert DL, Barnett AG, Clarke P, Graves N. On the time spent preparing grant proposals: an observational study of Australian researchers. BMJ Open. 2013;3(5):e002800. doi:10.1136/bmjopen-2013-002800 read 9 October 2026. doi.org/10.1136/bmjopen-2013-002800
- Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Annals of Internal Medicine. 2013;158(3):200-207. doi:10.7326/0003-4819-158-3-201302050-00583 read 9 October 2026. doi.org/10.7326/0003-4819-158-3-201302050-00583
- Abdoul H, Perrey C, Amiel P, et al. Peer Review of Grant Applications: Criteria Used and Qualitative Study of Reviewer Practices. PLoS ONE. 2012;7(9):e46054. doi:10.1371/journal.pone.0046054 read 9 October 2026. doi.org/10.1371/journal.pone.0046054
- National Institute of Allergy and Infectious Diseases (NIAID). Strategy for NIH Funding: Ten Steps to a Winning R01 Application. National Institutes of Health (NIAID). 2012. read 9 October 2026. ipr.osu.edu
- Proctor EK, Powell BJ, Baumann AA, et al. Writing implementation research grant proposals: ten key ingredients. Implementation Science. 2012;7(1):96. doi:10.1186/1748-5908-7-96 read 9 October 2026. doi.org/10.1186/1748-5908-7-96
- Hollins Martin CJ, Fleming V. A 15-step model for writing a research proposal. British Journal of Midwifery. 2011;18:791-798. read 9 October 2026. napier-repository.worktribe.com
- Eve J. Writing a research proposal: planning and communicating your research ideas effectively. Library and Information Research. 2009;32(102):18-28. doi:10.29173/lirg92 read 9 October 2026. doi.org/10.29173/lirg92
- SUNY Geneseo Sponsored Research (adapted from Locke, Spirduso and Silverman, Proposals That Work, 2nd ed., Sage, 1987). Common Reasons Grant Proposals Are Rejected. SUNY Geneseo Office of Sponsored Research. read 9 October 2026. geneseo.edu
- National Institute of Mental Health. Grant Writing Assistance. National Institutes of Health (NIMH). read 9 October 2026. nimh.nih.gov
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 9). The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria. Pubrica. https://pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/
Pubrica Academy. “The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria.” Pubrica, 9 Oct. 2026, pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/.
Pubrica Academy (2026) The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria. Pubrica. Available at: https://pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/ (Accessed: 15 October 2026).
Pubrica Academy. “The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria.” Pubrica. October 9, 2026. https://pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/
Pubrica Academy, ‘The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria’ (Pubrica, 9 October 2026) <https://pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/> accessed 15 October 2026.
Pubrica Academy. The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria. [Internet]. Pubrica; 2026 Oct 9 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/
Pubrica Academy, “The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria,” Pubrica, Oct. 9, 2026. [Online]. Available: https://pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/
@misc{essential_ingredients_of_a_scientific__2026,
author = {{Pubrica Academy}},
title = {The Essential Ingredients of a Medical Research Proposal: Components, Common Weaknesses and Reviewer Criteria},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/research/essential-ingredients-of-a-scientific-research-proposal-for-medical-science/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Ingredient completeness audit, by function
For each ingredient, the sentence in the draft that serves its function should be recorded — not the heading, but the sentence. Any row for which no sentence can be quoted represents a section that exists in name only, which is precisely what reviewers record as a weakness.
PROPOSAL INGREDIENT AUDIT
For each row: quote the actual sentence or figure from your draft that
does the job. "It is in section 3" does not count.
1. TITLE
Must: name population, intervention or exposure, and outcome
My title: ____________________________________________
[ ] Population named [ ] Intervention named [ ] Outcome named
2. ABSTRACT OR SUMMARY
Must: carry question, design, population, primary outcome, deliverable
Question sentence: ______________________________
Design sentence: ______________________________
Primary outcome sentence: ______________________________
Deliverable sentence: ______________________________
[ ] Written AFTER the body, not before
3. BACKGROUND AND RATIONALE
Must: make the objectives unavoidable
The gap paragraph, quoted: ______________________________
[ ] Organised by claim, not chronologically
[ ] A reader could predict my objectives after reading it
4. THEORETICAL OR CONCEPTUAL FRAMEWORK
Must: commit to a mechanism that predicts an observation
Mechanism stated: ______________________________
If right, we observe: ______________________________
If wrong, we observe: ______________________________
DELETION TEST:
[ ] I deleted every mention of the framework
[ ] Objectives, measurements or analysis CHANGED as a result
(if nothing changed, the framework is decoration)
5. OBJECTIVES
Primary (one only): ______________________________
Secondary (5 or fewer, each answerable alone):
1. ____________ 2. ____________ 3. ____________
4. ____________ 5. ____________
[ ] Each has a measurable endpoint
[ ] No co-primary objectives
6. DESIGN AND METHODS
Design named: ______________________
Population and setting: ______________________
Comparator: ______________________
Measurement and instrument: ______________________
[ ] A competent reader could reproduce this
[ ] No sentence is purely a statement of intent
7. STATISTICAL CONSIDERATION
Primary comparison: ______________________________
Analysis that tests it: ______________________________
Target difference: ______ Source for it: ______________
[ ] Stated as a judgement, with the consequence of being wrong
Variability: ______ Source: ______ Population it came from: ____
Alpha: ______ Power: ______
Attrition assumed: ______ Source: ______________
Clustering or design effect, if any: ______ Source: ______
Final sample size: ______
Secondary objectives powered individually? yes / no
[ ] If no, this is stated and they are reported as estimates
Missing data approach: ______________ Assumption: ____________
Sensitivity analysis: ______________________
Definition of "missing primary outcome": ______________________
Statistician named: ______________ Effort allocated: ______
8. PRELIMINARY DATA
Claim Evidence attached
____________________________ ____________________________
____________________________ ____________________________
____________________________ ____________________________
[ ] No sentence asserts a capability without evidence
Gaps declared, with mitigation: ______________________________
9. FEASIBILITY, TEAM AND ENVIRONMENT
Person Contribution Letter?
__________________ __________________________ ______
__________________ __________________________ ______
__________________ __________________________ ______
[ ] No named person has an unspecified contribution
Access and facilities: ______________________________
10. ETHICS AND GOVERNANCE
Consent route: ______________________________
Approval route and lead time: ______ weeks
Data protection: legal basis ______ controller ______
retention ______ transfers ______
Vulnerable groups: included / excluded, and why ______________
11. TIMELINE AND MILESTONES
[ ] Work decomposed into labelled units
[ ] Each unit has an owner, dates and a deliverable
[ ] Each unit has a stated consequence of failure
[ ] Critical path identified
12. BUDGET AND JUSTIFICATION
[ ] Costed by task, not by role
Present and costed, not assumed:
[ ] Data management [ ] Monitoring [ ] Statistical input
[ ] Governance submissions [ ] Participant reimbursement
[ ] Publication charges [ ] Archiving beyond the award
[ ] Budget realism sense-checked: not implausibly low or high
13. DISSEMINATION AND OUTPUT
What is published, and when: ______________________________
Who else receives the result: ______________________________
NON-SCIENTIFIC INGREDIENTS (these stop applications before review)
Sponsor deadline ................................ ______________
Institutional cut-off [a DIFFERENT date] ....... ______________
Page limit ...................................... ______
References count against the limit? yes / no
Font, margin, spacing rules met? yes / no
Section order as specified? yes / no
Eligibility confirmed? yes / no Evidence: ______________
Every required attachment in hand:
____________________________ [ ]
____________________________ [ ]
____________________________ [ ]
____________________________ [ ]
PAGE ALLOCATION (decide before drafting; hold it)
Introduction ..................... ______ pp (cap at 1)
Background and rationale ......... ______ pp
Framework ........................ ______ pp
Objectives ....................... ______ pp
Design and methods ............... ______ pp (largest share)
Statistical consideration ........ ______ pp
Preliminary data ................. ______ pp
Feasibility and team ............. ______ pp
Risks and alternatives ........... ______ pp
Timeline ......................... ______ pp
TOTAL ............................ ______ pp LIMIT: ______ pp
[ ] Total equals the limit
[ ] When over, scope was cut rather than detail
THE FOUR THINGS NO INGREDIENT LIST CONTAINS
A. INTERNAL CONSISTENCY
[ ] Objectives, methods, statistics, timeline and budget use the
same labels and the same numbers
[ ] Checked as a separate pass, not while drafting
Discrepancies found and fixed: ______________________
B. DECLARED RISK
Risk Mitigation
___________________________ ___________________________
___________________________ ___________________________
___________________________ ___________________________
[ ] Every risk is named by me, not left for the reviewer
C. THE NEGATIVE RESULT
If the primary result is null, the study still shows:
____________________________________________
[ ] The study is adequately sized for that null to mean something
D. LEGIBILITY TO A NON-SPECIALIST
[ ] A competent outsider read the first page and could restate
the question
Who read it: ______________ Date: ______________
[ ] The mechanism is followable without my subfield's vocabulary
WEAKEST INGREDIENT (fix this one first)
My weakest ingredient is: ______________________
Why: ______________________________
What raising it to adequate requires: ______________________
[ ] Fixed before improving anything already strong
(reviewer priorities spread across nine criterion domains, so the
weak section decides the outcome whenever its domain leads) Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica audits a proposal ingredient by ingredient against the function each must serve, which differs from confirming that the sections exist. Particular attention is given to the three ingredients that reviewers most often record as underdeveloped — the framework, the preliminary data and the statistical consideration. The sample-size argument is reconstructed from its inputs with the involvement of a statistician, and a reconciliation pass is conducted across the objectives, methods, timeline and budget, which authors reading their own text sequentially are seldom able to perform.